| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014942628 |
| P356 | DOI | 10.1023/A:1005753610355 |
| P698 | PubMed publication ID | 9151219 |
| P2093 | author name string | Soloway AH | |
| Barth RF | |||
| Goodman JH | |||
| Gahbauer RA | |||
| Blue TE | |||
| P2860 | cites work | Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study | Q34239497 |
| A review: CNS effects and normal tissue tolerance in dogs | Q36860882 | ||
| Fast neutron and mixed (neutron/photon) beam teletherapy for grades III and IV astrocytomas | Q39605781 | ||
| Fast neutron therapy for malignant astrocytomas. A review | Q39749274 | ||
| Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors | Q41251054 | ||
| The future role of neurosurgery in the care of cerebral tumors | Q41363204 | ||
| Comparison of measured parameters from a 24-keV and a broad spectrum epithermal neutron beam for neutron capture therapy: an identification of consequential parameters | Q41993436 | ||
| Cancer statistics, 1995. | Q43686273 | ||
| Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function | Q48661779 | ||
| Neuropathologic study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture radiation | Q48786081 | ||
| Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption. | Q50539878 | ||
| Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron Compounds | Q51210966 | ||
| Pathological study of eight patients with glioblastoma multiforme treated by neutron-capture therapy using boron 10. | Q51337497 | ||
| The possible use of slow neutrons plus boron10 in therapy of intracranial tumors. | Q51357331 | ||
| Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. | Q55480382 | ||
| Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Radiation Therapy Oncology Group. | Q55486282 | ||
| Fast neutrons compared with megavoltage X-rays in the treatment of patients with supratentorial glioblastoma: A controlled pilot study | Q55491024 | ||
| Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy | Q72402843 | ||
| Design of a high-flux epithermal neutron beam using 235U fission plates at the Brookhaven Medical Research Reactor | Q72577651 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 9-18 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | The rationale and requirements for the development of boron neutron capture therapy of brain tumors | |
| P478 | volume | 33 |
| Q55476193 | A Monte Carlo dosimetry-based evaluation of the 7Li(p,n)7Be reaction near threshold for accelerator boron neutron capture therapy. |
| Q39830722 | A novel method of boron delivery using sodium iodide symporter for boron neutron capture therapy |
| Q48767187 | An investigation on the use of removal-diffusion theory for BNCT treatment planning: a method for determining proper removal-diffusion parameters |
| Q46669051 | Capillary electrophoresis of boron cluster compounds in aqueous and nonaqueous solvents |
| Q48192695 | Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy |
| Q83560112 | Emerging subject for chiral separation science: cluster boron compounds |
| Q46383246 | Syntheses and preliminary biological studies of four meso-Tetra[(nido-carboranylmethyl)phenyl]porphyrins |
| Q38986162 | Synthesis, characterization and biological evaluation of carboranylmethylbenzo[b]acridones as novel agents for boron neutron capture therapy |
| Q48274699 | Synthesis, toxicity and biodistribution of two 5,15-di[3,5-(nido-carboranylmethyl)phenyl]porphyrins in EMT-6 tumor bearing mice |
Search more.